Filing Details
- Accession Number:
- 0001628280-24-051875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-18 16:14:42
- Reporting Period:
- 2024-12-17
- Accepted Time:
- 2024-12-18 16:14:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1953943 | Benjamin Halladay | C/O Esperion Therapeutics, Inc. 3891 Ranchero Drive, Suite 150 Ann Arbor MI 48108 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-17 | 3,245 | $2.42 | 240,691 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
Billionaire Hedge Funds
